Arkadiusz Robert Krzyżanowski

Dr. Arkadiusz Robert Krzyżanowski

Chair, Department of Obstetrics and Pathology of Pregnancy, Medical University of Lublin, 20-081 Lublin, Poland
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
IDIzabela Dymanowska-Dyjak
Izabela Dymanowska-Dyjak
ASAleksandra Stupak
Aleksandra Stupak
AKAdrianna Kondracka
Adrianna Kondracka
TGTomasz Gęca
Tomasz Gęca
Arkadiusz Robert KrzyżanowskiArkadiusz Robert Krzyżanowski
Arkadiusz Robert Krzyżanowski
Anna KwaśniewskaAnna Kwaśniewska
Anna Kwaśniewska
Preterm birth (PTB) is the leading cause of perinatal morbidity and mortality. Its etiopathology is multifactorial; therefore, many of the tests contain the assessment of the biochemical factors and ultrasound evaluation of the cervix in patients at risk of preterm delivery. The study aimed at evaluating the socioeconomic data, ultrasound examinations with elastography, plasma concentrations of MMP-8 and MMP-9 metalloproteinases, and vaginal secretions in the control group as well as patients with threatened preterm delivery (high-risk patients). The study included 88 patients hospitalized in the Department of Obstetrics and Pregnancy Pathology, SPSK 1, in Lublin. Patients were qualified to the study group (50) with a transvaginal ultrasonography of cervical length (CL) ≤ 25 mm. The control group (38) were patients with a physiological course of pregnancy with CL > 25 mm. In the study group, the median length of the cervix was 17.49 mm. Elastographic parameters: strain and ratio were 0.20 and 0.83. In the control group, the median length of the cervix was 34.73 mm, while the strain and ratio were 0.20 and 1.23. In the study group, the concentration of MMP-8 in the serum and secretions of the cervix was on average 74.17 and 155.46 ng/mL, but in the control group, it was significantly lower, on average 58.49 and 94.19 ng/mL. The concentration of MMP-9 in both groups was on the same level. Evaluation of the cervical length and measurement of MMP-8 concentration are the methods of predicting preterm delivery in high-risk patients. The use of static elastography did not meet the criteria of a PTB marker.

Arkadiusz Robert KrzyżanowskiArkadiusz Robert Krzyżanowski
Arkadiusz Robert Krzyżanowski
TGTomasz Gęca
Tomasz Gęca
BSBożena Sokołowska
Bożena Sokołowska
MKMaciej Kwiatek
Maciej Kwiatek
AMAndrzej Miturski
Andrzej Miturski
AKAnna Kwaśniewska
Anna Kwaśniewska
Introduction: Factor VII (FVII) deficiency is a rare hemorrhagic diathesis. In females, heavy menstrual and postpartum bleeding can appear as a consequence of its deficiency. Supplementation of the recombinant FVIIa is widely accepted. The supplementation effect in FVII-deficient subjects is difficult to predict, and severe hemorrhage has been described even when FVII levels after supplementation were within normal ranges. The aim of this report is to present the application of thromboelastometry to control the coagulation status in a patient with severe FVII deficiency during pregnancy and delivery, supplemented by rFVIIa per protocol complicated with life-threatening venous thromboembolism. Methods: Rotational thromboelastometry (ROTEM) was performed in 16 pregnant women: in one 28 year old primigravida at 35 weeks of pregnancy with congenital FVII deficiency after rFVIIa administration and 15 healthy women at 38 gestational weeks. The results were compared. Results: The thromboelastometry results showed significant shortening of the clotting time in the extrinsic and the intrinsic pathway in the hypoproconvertinemia patient after rFVIIa administration in relation to healthy pregnant women. A significant reduction in maximum lysis of the clot after FVII supplementation was observed. Conclusions: The thromboelastometry results showed a significant hypercoagulable state with hypoproconvertinemia. Thrombotic complications after delivery might be prevented by the reduction in rFVIIa guided by thromboelastometry. Thromboelastometry performed on a pregnant woman with factor VII deficiency during the supplementation of rFVIIa in peripartum time might be helpful in order to determine an individual, effective dosage regimen of rFVIIa to ensure full correction of clotting disorders without the tendency to develop thrombosis, but further studies are needed.

10 August 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
TGTomasz Gęca
Tomasz Gęca
MKMaciej Kwiatek
Maciej Kwiatek
Arkadiusz Robert KrzyżanowskiArkadiusz Robert Krzyżanowski
Arkadiusz Robert Krzyżanowski
Anna KwaśniewskaAnna Kwaśniewska
Anna Kwaśniewska
Background: Gestational diabetes mellitus (GDM) is the most common metabolic disorder in pregnant women, defined as any degree of glucose intolerance with onset or first detected during pregnancy. Explanation of its pathogenesis is extremely important due to the possibility of preventing serious maternal and fetal complications. The aim of the study was to evaluate the concentrations of two molecules: C1q/tumor necrosis factor-related protein-3 (CTRP-3) and pigment epithelium-derived factor (PEDF) which may possibly participate in GDM development. To our knowledge, this is the first study in pregnant women with GDM evaluating CTRP-3 level. Methods: Serum CTRP-3 and PEDF concentration and clinical characteristics were detected in 172 pregnant women. These women were divided into two groups: normal glucose tolerance group (NGT, n = 54) and gestational diabetes mellitus group (GDM, n = 118). This second group was further divided into two subgroups depending on the treatment used: GDM 1—diet only (n = 75) and GDM 2—insulin treatment (n = 43). Results: Our study did not reveal any statistically significant difference between the concentration of PEDF in the control and GDM group. In our study there was a significantly higher concentration of CTRP-3 evaluated in the peripheral blood serum in patients with gestational diabetes (GDM) compared to those in the control group (8.84 vs. 4.79 ng/mL). Significantly higher values of CTRP-3 were observed in both the diet-treated subgroup and the group with insulin therapy when compared to control group (8.40 and 10.96, respectively vs. 4.79 ng/mL). Conclusion: PEDF concentration does not change in GDM, whereas an increased level of CTRP-3 may point to the key role of this adipokine in the development of GDM.

12 March 2014 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
TGTomasz Gęca
Tomasz Gęca
Arkadiusz Robert KrzyżanowskiArkadiusz Robert Krzyżanowski
Arkadiusz Robert Krzyżanowski
ASAleksandra Stupak
Aleksandra Stupak
AKAnna Kwaśniewska
Anna Kwaśniewska
TPTomasz Pikuła
Tomasz Pikuła
RPRadoslaw Pietura
Radoslaw Pietura
Ultrasonography is used routinely during pregnancy to screen and detect fetal abnormalities. However, there are some conditions like anhydramnios (a prevalent state in renal agenesis) or maternal obesity that may limit the diagnostic accuracy of ultrasonography. Magnetic resonance imaging has proven to be useful when ultrasound alone is insufficient to make a correct diagnosis.

27 May 2017 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
Arkadiusz Robert KrzyżanowskiArkadiusz Robert Krzyżanowski
Arkadiusz Robert Krzyżanowski
AKAdrianna Kondracka
Adrianna Kondracka
ASAleksandra Stupak
Aleksandra Stupak
KKKwaśniewska A. Kwaśniewska
Kwaśniewska A. Kwaśniewska